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The interactions of diglycine with sulphathiazole drug as a function of temperatures have been studied using volumetric 
and acoustic parameters. Densities and speeds of sound of diglycine in (0.001, 0.002, 0.005 and 0.010) mol·kg-1 aqueous 
solutions of sulphathiazole drug have been measured at five different temperatures of (288.15, 293.15, 298.15, 303.15 and 
308.15) K under 0.1 MPa pressure. From density data, the apparent molar volume, the partial molar volume and the standard 
partial molar volume of transfer for glycine from water to aqueous sulphathiazole solutions have been calculated. Partial 
molar isentropic compression and partial molar isentropic compression of transfer have been calculated from the speed of 
sound data. Transfer parameters by using cosphere overlap model have been explained on the basis of ionic-hydrophilic, 
hydrophilic-hydrophilic, hydrophilic-hydrophobic and hydrophobic-hydrophobic group interactions. To draw the conclusion 
from the volumetric and acoustic data, limiting apparent molar expansion as well as the hydration numbers have been 
studied. The calculated values of thermal expansion coefficient have small and positive values. All of these derived or 
calculated parameters are explained to understand the solvation behaviour and various types of interactions born in the 
ternary solutions of (dipeptide + drug + water) due to change in structure. We have also attempted to examine the 
temperature and concentration dependence of such interactions. 
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The interactions of water with the functional groups 
of proteins play important factor in determining the 
conformational stability of proteins1,2. The study of 
the solvent effect on the properties of model 
compounds such as amino acid/peptide is quite 
helpful in understanding water-protein interactions in 
solutions3. The partial molar volume and the related 
volumetric parameters of drug compounds in dilute 
aqueous solutions at different temperatures have been 
investigated by several authors4–8. Moreover, physico-
chemical and thermodynamic investigations of drug 
molecule with amino acid/peptide is of much 
significance in order to understand the nature and the 
extent of the patterns of interaction in solutions and 
their variations with temperature and composition. 
Importance of studying low molecular weight model 
compounds lies in the fact that one can systematically 
alter the structure and therefore contribution of side 
chain groups of amino acid / peptide can be seen 
easily9. Drug can interact with small peptides to 
change the conformation of proteins either by 
stabilizing or destabilizing them. The recognition of 
drug-peptide interactions in aqueous solution has 
always been a matter of interest10,11. It is generally 
accepted that proteins stabilize because of 
hydrophobic effect12, although there was a dispute 
reported by Makhatadze and Privalov13 who predicts 
that binding model describes well but then Franks14 
strongly argued in the article “Protein stability” 
regarding involvement of hydrophobicity rather than 
binding which is responsible for solubilising and 
denaturing effects. Although no definite principle has 
been laid down in predicting the effect of solvent on 
the structure and reactivity of solutes, but much 
progress has been achieved15-17. Diglycine is a 
dipeptide made up of two glycine molecules joined by 
peptide linkage and is used in the synthesis of more 
complicated peptides. Whereas sulphathiazole used as 
a short-acting sulfa drug, is additionally significant 
class of heterocyclic compound, found in numerous 
powerful biologically active antimicrobial drug18. 
Sulfathiazole is effective against a wide range of 
gram positive and gram negative pathogenic 
microorganisms. It has a role as an antiinfective 
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agent. To study this class of compounds with small 
peptide are of potential interest that can provide 
valuable information regarding the conformational 
stability of proteins in these solutions, their solubility, 
folding/unfolding character, solute-solute and solute-
solvent interactions19,20. 
There have been some source investigators in 
aqueous saccharide solutions21-24 but very few in 
aqueous drug solutions25-27 probably due to complex 
nature of their interactions. Our research group has 
attempted to quantify the bio-molecular interactions 
of biomolecules with drugs28,29. The systematic study 
of peptides with amphiphilic drug which enhances the 
probability of interactions with the biomolecules can 
provide valuable information about their behaviour in 
solutions and insight into the hydration of biological 
systems. For this purpose, it is necessary to 
investigate solutions of peptides with drugs. To this 
end, in the present paper, we report the density and 
speed of sound measurements of diglycine in aqueous 
drug solutions at T=(288.15 to 308.15) K and at 
atmospheric pressure from which the values for 
infinite dilution of apparent molar volumes are 
calculated with the help of least-square method30. The 
limiting apparent molar volumes, limiting apparent 
molar isentropic compression have been calculated in 
order to discuss the types of interactions i.e., solute-
solute or solute-solvent and also their nature of 
interactions (hydrophilic-hydrophilic, hydrophilic-
hydrophobic, and hydrophobic-hydrophobic), 
occurring in the ternary systems (dipeptide - drug- 
water) and its effect with temperature.  
Materials and Methods 
Diglycine (Loba Chemie Pvt. Ltd. Mumbai, 
minimum assay 99.0%) was used after drying over 
silica gel in a vacuum desiccator at room temperature. 
Sulphathiazole from Sigma Chemicals Co. was dried 
for 24 h in a vacuum desiccator before use. The 
structure of this drug is given in Fig. 1. 
Freshly prepared triple distilled and degassed water 
having specific conductance less than 10-6 S cm-1 was 
used for the preparation of solutions. Solutions of 
diglycine in the concentration range of 0.002 to 
0.01 mol·kg-1 were made by mass on the molality 
concentration scale with an accuracy of 1×10−5. All 
the components were mixed together to form different 
concentrations using an analytical balance (Afcoset 
ER – 182A) having a precision of ± 0.01 mg. The 
standard uncertainty recorded in molality as per stated 
purities were in the range  2×10−5 mol kg-1. To 
prevent the prepared mixtures from atmospheric 
moisture, cork was firmly applied on the glass vial 
just after the preparation. These mixtures were 
directly used to measure the density (  and speed of 
sound (  of the solutions by using vibrating–tube 
digital density and speed of sound analyzer (Anton 
Paar, DSA 5000 M, Austria) with a precision of 
± 1×10−3 kg·m-3 and 1x10-2 m·s-1 at five different 
temperatures T = (288.15, 293.15, 298.15, 303.15 and 
308.15) K and at atmospheric pressure. 
Before each series of measurements, the instrument 
was pre-calibrated with doubly distilled, deionised, 
degassed water, and dry air for the temperature range 
investigated. The maximal error in the measurements 
of density and speed of sound relative to water31,32 is 
estimated to be less than ± 1.5×10−1 kg·m-3 and 
 5 ×10-2 m·s-1. Both the measured properties are 
extremely sensitive to temperature, so it was 
controlled to ± 1×10−2 K by a built-in solid state 
thermostat. The apparatus was also tested with the 
density of a known molality of aqueous NaCl using 
the data given by Pitzer et al.33. Further details of the 
measurements and calibration of instrument have 
been described in our previous papers34,35. 
Results and Discussion 
Density, speed of sound and partial molar properties 
The  and  values of diglycine in aqueous 
sulphathiazole (0.001-0.01 mol·kg-1) solutions at 
T = (288.15 to 298.15) K have been reported in 
Table 1. The apparent molar volumes	  ×106 and 
the apparent molar isentropic compression (Ks,) of 
diglycine in aqueous sulphathiazole solution have 
been calculated from the experimentally measured 
densities and speeds of sound using the following 
equations and are given in Table 2. 
1000 … (1)
	Ks,  	 M / 		 	1000 ,  	 /  } … (2) Fig. 1 ― Structure of sulphathiazole drug 




where /kg mol-1 is the molar mass of diglycine and 
ρ, ρo, βS and βS,0 are the densities in kg m
-3 and 
coefficient of molar isentropic compression of 
solution and the solvent (drug+water) in Pa-1 and  
mA is the molality of solute in kg mol
-1, that is, 
diglycine in solutions. The coefficient of molar 
isentropic compression has been calculated by the 
following Laplace- Newton’s equation 
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(m s-1)  
0.001 mB sulphathiazole + diglycine 
0.00000 0.999217 1466.56 0.998312  1482.90 0.997145 1497.10 0.995738 1509.56 0.994117 1520.23 
0.00218 0.999314 1466.69 0.998408 1483.07 0.997239 1497.34 0.995831 1509.85 0.994208 1520.58 
0.00569 0.999492 1467.28 0.998586 1483.72 0.997410 1498.31 0.996001 1510.97 0.994376 1521.82 
0.00847 0.999652 1468.06 0.998746 1484.55 0.997564 1499.59 0.996154 1512.49 0.994527 1523.39 
0.01000 0.999748 1468.63 0.998842 1485.12 0.997656 1500.48 0.996245 1513.58 0.994618 1524.48 
0.005 mB sulphathiazole + diglycine 
0.00000 0.999728 1467.17 0.998818 1483.45 0.997640 1497.67 0.996233 1509.99 0.994607 1520.60 
0.00212 0.999821 1467.28 0.99891 1483.61 0.997730 1497.89 0.996321 1510.25 0.994692 1520.90 
0.00499 0.999961 1467.64 0.999049 1484.00 0.997866 1498.33 0.996455 1510.74 0.994823 1521.44 
0.00801 1.000126 1468.26 0.999215 1484.65 0.998027 1498.99 0.996614 1511.41 0.994978 1522.18 
0.01073 1.000293 1469.02 0.999379 1485.41 0.998187 1499.73 0.996773 1512.16 0.995135 1522.96 
0.01 mB sulphathiazole + diglycine 
0.00000 1.000315 1468.52 0.999398 1484.50 0.998217 1498.74 0.996802 1510.71 0.995166 1521.69 
0.00220 1.000409 1468.63 0.999491 1484.62 0.998307 1498.94 0.996891 1510.95 0.995252 1521.98 
0.00516 1.000552 1468.76 0.999633 1484.78 0.998446 1499.20 0.997028 1511.27 0.995384 1522.40 
0.00839 1.000730 1468.88 0.999811 1484.95 0.99862 1499.47 0.997198 1511.61 0.99555 1522.89 
0.01003 1.000829 1468.93 0.999910 1485.04 0.998718 1499.60 0.997294 1511.78 0.995644 1523.16 
mA is the molality diglycine in water - drug solvent systems; mB is the molality of drug in water; Standard uncertainties, U, are U(T) =  ± 
0.01 K, U(p) = ± 0.01 MPa, U(ρ) = ±  1.5×10−1 kg·m-3, and U(u) =   5 ×10-2 m·s-1 
 
Table 2 ― Apparent molar volume 
V , and apparent molar isentropic compression sK , , of diglycine in aqueous  solutions of 





6 (m3 mol-1) 
sK , ·×10
6 (m3 mol-1GPa-1) 
288.15 293.15 298.15 303.15 308.15 288.15 293.15 298.15 303.15 308.15 
0.001 mB sulphathiazole + diglycine 
0.00218 87.65 88.15 89.12 89.65 90.65 -17.6 -27.4 -44.3 -55.5 -68.4 
0.00569 83.79 84.00 85.64 86.04 86.82 -63.5 -71.6 -108.0 -125.0 -138.0 
0.00847 80.75 80.90 82.71 83.11 83.89 -98.3 -105.0 -159.0 -184.0 -193.0 
0.01000 79.00 79.12 81.06 81.51 82.17 -119.0 -123.0 -186.0 -217.0 -224.0 
0.005 mB sulphathiazole + diglycine 
0.00212 88.26 88.77 89.77 90.79 92.30 -12.2 -25.4 -39.7 -48.6 -56.3 
0.00499 85.42 85.85 86.91 87.77 89.06 -41.6 -49.2 -59.3 -67.2 -74.2 
0.00801 82.41 82.56 83.86 84.66 85.98 -70.9 -76.4 -81.4 -85.4 -93.0 
0.01073 79.43 79.82 81.17 81.87 83.05 -96.7 -98.9 -99.9 -102.0 -108.0 
0.01 mB sulphathiazole + diglycine 
0.00220 89.37 89.87 91.29 91.82 93.28 -10.0 -17.2 -31.6 -40.0 -50.1 
0.00516 86.16 86.58 87.80 88.44 90.08 -12.0 -18.0 -33.4 -42.6 -56.1 
0.00839 82.61 82.88 84.12 85.01 86.51 -14.1 -18.9 -35.4 -44.9 -62.2 
0.01003 80.82 81.05 82.19 83.13 84.60 -14.8 -19.2 -36.2 -46.2  -65.8 




Since, for diglycine, a linear dependence of both 
the apparent molar volumes 	 ) and the apparent 
molar isentropic compression (Ks,) on the molality 
(mA) was observed over the concentration range 
studied. Furthermore, both the values show an 
increase with the chain length i.e., from glycine36 to 
diglycine at all the temperatures. Due to the presence 
of polar groups both on drug as well as on diglycine, 
the structure enhancing ability of peptide in the 
solution are improved. 
The apparent molar volumes at infinite dilution 
) and limiting apparent molar isentropic 
compression ( , ) are obtained by the linear 
regression analysis of the V and Ks, data using the 
following equation 
 
 … (4) 
where  (denotes  or , ) is the limiting value of 
the apparent partial molar property that is equal to the 
infinite dilution partial molar property and SQ 
(denotes Sv or SK ) is the experimental or limiting 
slope indicative of solute-solute interactions. The  
or ,  at infinite dilution and Sv or SK with standard 
errors obtained by the least square fitting of V and 
Ks, data using Eqn.(4) are summarized in Table 3.  
The V and Ks, were found to be a linear function 
of mA, in the concentration range studied. The V and 
Ks, data have been used to see the effect of 
temperature and drug concentration on solute-solvent 
interactions occurring in the ternary mixtures of the 
present study. Table 3 reveals that diglycine studied 
here has large positive  values and negative  
,
(Ref 17) values in aqueous sulphathiazole solutions 
(except at lower temperature and at lower 
sulphathiazole concentrations), which indicates  
Table 3 ― Partial molar properties, 0V (m
3 mol-1),  sK , (m
3 mol-1GPa-1) and their corresponding slopes, Sv (m
3 kg mol-3/2)  
and SK (kg m 
3 mol-2GPa-1) of diglycine in aqueous solutions of sulphathiazole drug at different temperatures 
Properties T(K) 
288.15 293.15 298.15 303.15 308.15 
Diglycine in water 
0
V ·× 10
6 74.14( ± 0.02) [24] 74.63( ± 0.03)* 75.24(± 0.05) [24] 75.57 (± 0.03)* 76.21( ± 0.02) [24] 
Sv·× 10
6 5.37( ± 0.17) 5.40(( ± 0.02) 5.44( ± 0.13) 5.32(± 0.02) 5.22( ± 0.14) 

,sK ·10
6 -43.58( ± 0.22) [22] -41.64( ± 0.25)* -39.64( ± 0.20) [22] -37.54(± 0.18)* -35.57( ± 0.01) [22] 
SK·× 10
6 2.30( ± 1.11) 6.74( ± 1.04) 7.94( ± 1.13) 8.46( ± 0.64) 8.49( ± 0.72) 
0.001 mB sulphathiazole + diglycine 
0
V ·× 10
6 90.06( ± 0.03) 90.62( ± 0.07) 91.41( ± 0.09) 91.93( ± 0.03) 92.99( ± 0.05) 
Sv·× 10
6 -1103.64( ± 5.31) -1151.6( ± 10.26) -1030.3( ± 13.64) -1041.63( ± 4.26) -1080.56( ± 6.93) 

,sK ·× 10
6 10.42( ± 0.73) -1.21( ± 0.92) -4.76( ± 0.48) -9.37( ± 2.11) -24.97( ± 0.37) 
SK ·× 10
6 -12911.2( ± 101.1) -12230.8( ± 128.2) -18156.3( ± 67.07) -20363.1( ± 292.9) -19874.2( ± 51.6) 
0.005 mBsulphathiazole + diglycine 
0
V ·× 10
6 90.48( ± 0.124) 91.00( ± 0.08) 92.38(±0.10) 92.96(±0.03) 94.50( ± 0.10) 
Sv·× 10
6 -1022.13( ± 17.29) -1044.98( ± 11.09) -1042.48(±13.97) -1035.39(±4.31) -1068.5( ± 14.5) 

,sK ·10
6 8.00( ± 0.86) -6.97( ± 0.75) -24.66(±0.52) -35.93(±0.63) -43.9( ± 0.86) 
SK ·× 10
6 -9803( ± 119.2) -8588.09( ± 103.8) -7027.6(±72.04) -6176.75(±87.81) -6030.6( ± 119.7) 
0.01 mBsulphathiazole + diglycine 
0
V ·× 10
6 91.78( ± 0.01) 92.37( ± 0.03) 93.82(±0.04) 94.21(±0.08) 95.74( ± 0.07) 
Sv·× 10
6 -1092.78( ± 2.20) -1128.93( ± 5.05) -1159.15(±5.98) -1103.27(±12.14) -1106.51( ± 10.10) 

,sK ·× 10
6 -8.71( ± 0.21) -16.64( ± 0.07) -30.32(±.106) -38.38(±0.17) -45.74( ± 0.20) 
SK ·× 10
6 -622.8( ± 29.6) -260.24( ± 10.88) -594.08(±14.98) -782.68(±25.27) -1986.12( ± 31.70) 
*Obtained through extrapolation; Expanded uncertainties, Uexp. are Uexp.( V ) = ± 0.05.10
-6 m3 mol-1 , and Uexp.( sK , ) = ± 0.04.10
-6 m3
mol-1 GPa-1; Corresponding references are given in the square bracket 
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the presence of strong dipeptide – drug-water22 
interactions. The  values increase from glycine36 to 
diglycine with the order of the increase of the molar 
mass or peptide linkage. Further, the values increase 
with increasing temperature and also with increase in 
the concentration of sulphathiazole. This signifies that 
solute-solvent interaction increases30,35 both with an 
increase in the concentration of sulphathiazole and 
temperature. This is due to the reduction in the 
electrostriction surrounding the zwitterion. This 
interaction results from the release of some water 
molecules from the loose solvation shell of the solute 
(diglycine) in the bulk solution. As a result, there is 
expansion in volume of the solution. That is, the 
maximum structure-breaking effect of diglycine takes 
place in higher concentrations of sulphathiazole and at 
higher temperature. Moreover, , , values are 
negative for diglycine but higher in magnitude than 
glycine36 in aqueous sulphathiazole solutions. The 
negative ,  values indicate that water molecules 
around the solute are less compressible than water 
present in the bulk. This feature is similar to that 
observed for diglycine in aqueous solutions of 
saccharides or cyclodextrin17,22,24,30. The experimental 
 values in Table 3 for diglycine in sulphathiazole 
are found to be negative but smaller than the 
 values, suggesting that solute-solute interactions 
are weaker than solute-solvent interaction in the 
system under study. 
Partial molar properties of transfer 
The transfer partial molar volume of transfer ( ∘) 
and partial molar isentropic compression of transfer 
( ,
∘ ) of diglycine from water to aqueous solutions 
of sulphathiazole drug have been determined as   
∘ 	 	 	  (in 
water)  … (5) 
The experimental values   and ,  for diglycine 
in water have been taken from our previous works22,24. 
Table 4 and Figs. 2 and 3 show that ∘ are positive 
and ,
∘  are also positive (except for diglycine at 
higher concentrations of sulphathiazole and at higher 
temperatures). The ∘ value can further be 
explained on the basis of cosphere overlap model37,38. 
According to this model ionic-hydrophilic 
and hydrophilic - hydrophilic group interactions 
contribute positively, whereas hydrophilic- 
Table 4 ― Transfer partial molar volumes, 
Vtr and transfer partial molar isentropic compressions, 

str K , of diglycine in aqueous 




Vtr  × 10
6 (m3 mol-1) 
str K , × 10
6 (m3 mol-1 GPa-1) 
288.15 293.15 298.15 303.15 308.15 288.15 293.15 298.15 303.15 308.15 
Sulphathiazole + diglycine 
0.001 15.92 15.99 16.07 16.36 16.90 54.00 40.43 35.04 28.17 10.6 
0.005 16.34 16.37 17.14 17.39 18.41 51.58 34.67 15.14 1.61 -8.33
0.01 17.64 17.74 18.58 18.64 19.65 34.87 25.00 9.48 -0.84 -10.17
Fig. 2 ― Plot of transfer partial molar volume, ∘at infinite 
dilution versus molality of sulphathiazole drug at T= (■, 288.15 
K; ●, 293.15 K; ▲, 298.15 K; ▼, 303.15 K; ○, 308.15 K) 
Fig. 3 ― Plot of transfer partial molar isentropic
compression, ,
∘  at infinite dilution versus molality of
sulphathiazole drug at T= (■, 288.15 K; ●, 293.15 K; ▲, 298.15
K; ▼, 30315 K; ○, 308.15 K) 




hydrophobic and hydrophobic- hydrophobic group 
interactions contribute negatively to the ∘ values. 
It can  be seen in Table 4 and Fig. 2 that the positive 
transfer volume ∘ for diglycine increases with 
increasing concentration of drug and at all of the 
temperatures. It may be concluded that in the ternary 
solutions, the increased concentrations of drug lead to 
greater ionic-hydrophilic and hydrophilic-hydrophilic 
interactions between NH3
+ and COO- group of 
diglycine and sulfuric( )group of sulpha drugs 
that are not influenced by the hydrophilic-
hydrophobic interactions. Thus, it promotes the 
structure making ability of solute in the solution due 
to hydrophilic interactions between them. 
The ,
∘  values decrease both with increase in 
concentration of sulphathiazole drug and temperature. 
The positive value ,
∘  indicates the dominance of 
the charged end groups NH3
+ and COO-. The 
interactions between sulphathiazole drug and 
zwitterionic centre of diglycine increase with drug 
concentration. Increase in the concentration of drug 
leads to electrostriction decreases and structure making 
tendency of the ions increases2. That is, the release of 
water molecules to solvent bulk occurs due to disruption 
of hydration sphere of the charged end centers of 
diglycine and sulphathiazole drug. As a result, it leads to 
large decrease in the compressibility with increase in 
sulphathiazole concentration. Thus, Ks,
0 values are 
negative and ,
∘ values are positive. 
The pair and triplet interaction coefficients 
estimated from ∘ and ,
∘  values as given by 
McMillan et al.39 and Millero et al.40 by using the 
following equation, 
 
∘ 	 	 	 	 2 3   
… (6) 
 
where, the constants YAB and YABB are pairwise and 
triplet interaction coefficients. Here A denotes 
diglycine, B denotes the cosolute (drugs), and mB is 
the molality of the cosolute.  The  ∘  values have 
been fitted to Eqn. (6) to obtain YAB and YABB. The 
corresponding parameters VAB and VABB for volumes 
and KAB and KABB for isentropic compressions, 
estimated from ∘ and ,
∘  respectively, are 
listed in Table 5. The pair wise interaction 
coefficients VAB are positive for sulpha drug at all 
temperatures whereas triplet interaction coefficient 
VABB is negative except at 288.15 K for diglycine. 
Positive values for VAB strengthen our viewpoint that 
ionic/hydrophilic-hydrophilic interactions dominate over 
hydrophobic-ionic interactions between solute and 
cosolute molecules. The values of VAB for diglycine 
increase with increase in temperature. The pairwise 
interaction coefficient KAB corresponding to the 
isentropic compression is positive except at 308.15 K 
and it decreases with increase in temperature. 
 
Apparent molar expansibilities  
The temperature variation of  can be expressed as 
 
 … (7) 
 
where Tm represents the midpoint temperature of the 
range used (Tm =298.15 K). Least-square fitting of 
Eqn. (7) was done to obtain a, b and c parameters. 
Differentiation of Eqn. (7) with respect to temperature 
at constant pressure was done to calculate partial 
molar isobaric expansions 
 
		 ⁄ 2  … (8) 
 
It follows from Eqn. (8) that the quantity  
b+2c(T-Tm) is equivalent to . The calculated values 
of partial molar expansion ( ) at different 
temperatures are included in Table 6.  
Table 5 ― Pair, YAB and triplet, YABB interaction coefficients of 






(m 3 mol-2 
kg) 
VABB  × 
1011 








(m 3 mol-3 kg2 
GPa-1) 
Sulphathiazole + diglycine 
288.15 3.15 -1.54 11.0 -6.31 
293.15 3.15 -1.54 7.68 -4.36 
298.15 3.26 -1.58 4.58 -2.81 
303.15 3.32 -1.62 2.20 -1.56 
308.15 3.49 -1.70 -0.30 -1.67 
 
Table 6 ― Partial molar expansions, 0
2E at infinite dilution and 
isobaric thermal expansion coefficient, α2 of diglycine in aqueous 
solutions of sulphathiazole at different temperatures 




6 (m3 mol-1 K-1) 
288.15 293.15 298.15 303.15 308.15 
Sulphathiazole + diglycine 
0.001 -0.018 0.015 0.049 0.083 0.117 
0.005 0.056 0.080 0.103 0.127 0.150 
0.010 0.087 0.094 0.100 0.107 0.113 
α2 (K) 
Sulphathiazole + diglycine                              
0.001 -0.00021 0.00017 0.00054 0.00090 0.00012 
0.005 0.00062 0.00088 0.00112 0.00136 0.00159 
0.010 0.00095 0.00102 0.00107 0.00113 0.00118 





0values for any solute thought to be sensitive 
measure of solute-solvent interaction41. From Table 6, 
it has been seen that at each temperature E2
0 values in 
aqueous drug solution are increasing regularly with rise 
in temperature, and with the concentration of 
sulphathiazole drug except at higher temperatures and 
higher concentrations. It may be noted that E2
0 values 
are positive favouring the solute-solute interactions. 
The effect is that electrostricted water may be released 
from the loose salvation layer of diglycine. Removal of 
water molecules favours diglycine-drug or drug-drug 
interactions, indicating the value of partial molar 
expansibility gives information regarding the size of 
the solute and its hydrophobicity.The values of 	  and  
are further used to calculate the isobaric thermal 
expansion coefficient, α2 using following relation
42 
 
/  … (9) 
 
The α2 value increases with increase in temperature 
as well as with increase in concentration of 
sulphathiazole drug (except at higher concentration 
and higher temperature) indicating that dipeptide -
drug- water interaction increases as concentration of 
sulphathiazole drug increases. The calculated values 
of α2 are included in Table 6. 
 
Hydration Number 
The partial molar volume of the peptide can be 





0(elect) … (10) 
 
where V
0 (elect) is the electrostriction partial molar 
volume due to the hydration of the peptide and can be 
estimated from experimentally measured values of 
V
0(peptide), and V
0(int) is the intrinsic partial molar 
volume of the peptide and has been calculated from 
the following expressions40  
 
V
0(int) = (0.7/0.6) V
0(cryst) … (11) 
 
V
0(int) = (0.7/0.634) V
0(cryst) … (12) 
 
where V
0(cryst) (= M/dcryst) is the crystal molar 
volume and M its molar mass, 0.7 is the packing 
density for molecules in organic crystals and 0.634 is 
the packing density for random packing spheres. The 
values of V
0(int) for the peptide were estimated from 
Eqn. (11) and (12) using dcryst values for diglycine 
determined by single crystal X- ray diffraction is 
1.534 g cm3 taken from the references43,44. 
The change in volume due to electrostriction can be 
related to the number of water molecules nH hydrated 




0 V, b0)            … (13) 
 
where V, e
0 is the molar volume of electrostricted 
water and V, b
0 is the molar volume of bulk water 
(18.069 x 106 m3 mol-1 at 298.15 K). The reported 
value35,38 of (V, e
0 V, b0) is 3.3 x 10-6 m3 mol-1 at 
298.15 K. Further, the number of water molecules nH 
hydrated to the diglycine were calculated by using the 
method given by Millero et al.40 ,48 
 
nH = K,s0(elect)/ V, b0 Ks, b0            … (14) 
 
The values of nH calculated from Eqn. (13) and 
(14) using the V
0(elect) and Ks,
0(elect) values 
determined are listed in Table 7. It can be seen that 
the nH values calculated from partial molar volume 
data decrease with an increase in the concentration of 
sulphathiazole drug30. Similar results are observed 
between diglycine and sulpha drugs in aqueous 
solutions44. Again, this indicates that an increase in 
solute–cosolute interaction occurs with increase in 
concentration of antibiotic drug. This suggests that the 
interactions between the hydrophilic group of drugs 
and the charged end centers/polar groups of peptide 
become stronger with increase in the sulphathiazole 
concentrations. The values for the diglycine from 
compressibility data in the presence of sulphathiazole 
are less than in water and increases with the 
concentration of sulphathiazole. It again indicates the 
increase in the solute-cosolute interaction with 
increasing sulphathiazole drug concentrations as the 
number of solvent (water) molecules around solute 
goes on decreasing. Subsequently, solute-solvent 
Table 7 ― Hydration number, nH of diglycine in aqueous 
solutions of sulphathiazole at 298.15 K 
mB (mol kg
-1) Hydration number (nH) 
From volume From compressibility 




Using Eqn. 14 
0.000 7.65 6.02 4.91 
0.001 2.75 1.12 0.58 
0.005 2.50 0.82 3.04 
0.010 2.02 0.39 3.74 




interaction decreases. This clearly shows that 
sulphathiazole drug have a dehydrating effect on 
diglycine in aqueous solutions. Also, we can classify 




In this paper, we have presented the volumetric and 
acoustic properties of diglycine in aqueous 
sulphathiazole drug solutions at different 
temperatures. The apparent molar volume values are 
positive and apparent molar isentropic compression 
values are negative in aqueous drug solutions, 
indicating the presence of strong solute-solvent 
interactions. The transfer volumes of peptide from 
water to aqueous drug solutions are positive, 
suggesting that ionic-hydrophilic and hydrophilic - 
hydrophilic group interactions play a dominant role in 
these systems. Positive value of partial molar 
expansibility and pair wise interaction coefficient 
indicate the presence of strong solute-solute 
interaction. These results also confirm the structure 
making behaviour of diglycine in aqueous drug 
solution. Hydration number calculated from values of 
partial molar volume decreases with increase in 
concentration of sulphathiazole drug, indicating an 
increase in solute-solvent interactions. Therefore, 
such a study has great importance in future for 
formulation development in the pharmaceutical 
industry, drug delivery and physiological action. 
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